Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Ad Enforcement Steams On; Are “Days Of Pushing The Envelope” Over?

Executive Summary

FDA's aggressive enforcement of its advertising standards, and the agency's new enforcement allies, mean that industry may now have more to fear from a citation letter
Advertisement

Related Content

FDA's Executive Responsibility Policy Could Sweep In Board Members
FDA's Executive Responsibility Policy Could Sweep In Board Members
FDA's Drug Advertising Oversight Gets A Promotion From A Division To An Office
FDA Enforcement To Be More "Swift, Aggressive" As Centers Share Techniques
FDA Enforcement To Be More "Swift, Aggressive" As Centers Share Techniques
Chart: Numbers Don't Lie: Update on Citations of False and Misleading Advertising
Internet Ad Regulation: Industry Seeks To Develop Alternate Framework
Internet Promotions Must Be Redesigned After FDA Cites Sponsored Web Links
Internet Promotions Must Be Redesigned After FDA Cites Sponsored Web Links
Bayer Loses Oversight Of Yaz DTC Ads Under Agreement With States Attorneys General

Topics

Advertisement
UsernamePublicRestriction

Register

PS051089

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel